GILEAD SCIENCES, INC. - GILD

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$167.1B

QoQ value delta ($000)

+$31.88B (+23.57%)

Implied price effect (QoQ)

+11.9%

Total shares

1,218,363,314

QoQ shares delta

+115,003,096 (+10.42%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 2288 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
BlackRock, Inc.	16,586,559	119,010,973	0.29%
VANGUARD GROUP INC	14,863,487	121,097,336	0.22%
VANGUARD CAPITAL MANAGEMENT LLC	11,240,856	80,654,776	0.28%
FMR LLC	10,021,579	71,906,290	0.53%
STATE STREET CORP	8,342,490	59,858,585	0.29%
Capital World Investors	5,753,020	41,283,933	0.78%
VANGUARD PORTFOLIO MANAGEMENT LLC	4,895,993	35,129,465	0.26%
JPMORGAN CHASE & CO	4,634,525	33,992,410	0.3%
GEODE CAPITAL MANAGEMENT, LLC	4,135,590	29,726,052	0.26%
Capital Research Global Investors	3,780,727	27,127,533	0.59%
PRICE T ROWE ASSOCIATES INC /MD/	3,658,200	26,248,108	0.42%
DODGE & COX	3,379,837	24,250,826	1.86%
MORGAN STANLEY	3,247,223	23,299,295	0.2%
BANK OF AMERICA CORP /DE/	2,784,464	19,978,936	0.2%
NORGES BANK	2,617,152	21,322,732	0.28%
Invesco Ltd.	2,163,905	15,526,336	0.33%
Bank of New York Mellon Corp	2,099,880	15,066,951	0.39%
NORTHERN TRUST CORP	1,926,146	13,820,379	0.25%
WELLINGTON MANAGEMENT GROUP LLP	1,886,789	13,537,991	0.35%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1,839,558	13,199,103	0.38%
GOLDMAN SACHS GROUP INC	1,608,610	11,542,014	0.18%
Amundi	1,468,835	10,539,111	0.4%
Legal & General Group Plc	1,458,491	10,464,889	0.34%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	1,140,294	8,181,780	0.17%
Nuveen, LLC	1,091,763	7,833,564	0.3%